Gbola Amusa

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Gbola Amusa works at CHARDAN CAPITAL and is covering the Healthcare, Industrials sectors with 286 price targets and ratings documented since 2015 spanning on 25 stocks.

Gbola Amusa's average stock forecast success ratio is 57.95% with an average time for price targets to be met of 225.72 days.

Most recent stock forecast was given on MRNA, Moderna, Inc at 14-Dec-2022.

Wall Street Analyst Gbola Amusa

Analyst best performing recommendations are on SAGE (SAGE THERAPEUTICS, INC).
The best stock recommendation documented was for SAGE (SAGE THERAPEUTICS, INC) at 2/14/2017. The price target of $60 was fulfilled within 2 days with a profit of $5.67 (10.44%) receiving and performance score of 52.18.

Average potential price target upside

Currently, out of the existing stock ratings of Gbola Amusa - 4 which are a Buy (66.67%), 2 which are a Hold (33.33%)

ADVM AXON ESPR FOLD KRYS LJPC MDCO MGTX MRNA ONCE PASG PRVB QURE REGN RGNX SAGE SLDB VYGR AGTC IMVT MCRB TSHA ABUS FBRX VBLT

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

2

$0.65 (48.15%)

2.5

6 months 26 days ago

0/2 (0%)

$1.13 (114.91%)

Buy

4

$2.65 (196.30%)

9

10 months 30 days ago

4/6 (66.67%)

$1.45 (57.70%)

24

Hold

3

$1.65 (122.22%)

17

1 years 10 months 14 days ago

1/2 (50%)

$2.74 (33.46%)

7

Hold

2

$0.65 (48.15%)

5

1 years 10 months 14 days ago

3/5 (60%)

$3.07 (29.73%)

47

Hold

21

1 years 10 months 14 days ago

2/2 (100%)

$7.53 (88.83%)

197

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

To continue looking at which analysts cover the stock please register to the basic or advanced membership